|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61P 5/26 | (2006.01) | ||
| A61P 5/28 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2824102 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14188300.9 |
| Date of filing the European patent application | 2011-02-16 | |
| (97) | Date of publication of the European application | 2015-01-14 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 305082 P | 2010-02-16 | US | |
| 329023 P | 2010-04-28 | US | |
| 388457 P | 2010-09-30 | US |
| (72) |
Smith, Nicholas, D.,, US
Bonnefous, Celine,, US
Julien, Jackaline, D.,, US
|
| (73) |
Aragon Pharmaceuticals, Inc.,
12780 El Camino Real, Suite 301, San Diego, CA 92130,
US
|
| (54) | Androgen receptor modulators and uses thereof |
| Androgen receptor modulators and uses thereof |